Effects of prior feeding on pharmacokinetics and estimated bioavailability after oral administration of a single dose of microencapsulated erythromycin base in healthy foals

American Journal of Veterinary Research

Volumn 61, Issue 9, 2000, Pages 1011-1015

  Lakritz, Jeffrey ^a   Wilson, W David ^b   Marsh, Antoinette E ^a   Mihalyi, Judy E ^b  

^a UNIVERSITY OF MISSOURI   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG METABOLITE; ERYTHROMYCIN;

ANIMAL DISEASE; ANIMAL EXPERIMENT; ARTICLE; BACTERIAL INFECTION; DIET RESTRICTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; FOOD DRUG INTERACTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HORSE; MALE; MICROENCAPSULATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; RHODOCOCCUS;

ANIMALIA; BACTERIA (MICROORGANISMS); EQUUS CABALLUS; RHODOCOCCUS; RHODOCOCCUS EQUI;

EID: 0033865448     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.2000.61.1011     Document Type: Article

References (14)

1. Prescott JF, Nicholson VM. The effects of combinations of selected antibiotics on the growth of Corynebacterium equi. J Vet Pharmacol Ther 1984;7:61-64.
2. Ainsworth DM, Beck KA, Boalwright CE, et al. Lack of residual lung damage in horses in which Rhodococcus equi-induced pneumonia had been diagnosed. Am J Vet Res 1993;54:2115-2120.
3. Bernard B, Dugan J, Pierce S, et al. The influence of foal pneumonia on future racing performance, in Proceedings. 37th Annu Conv Am Assoc Equine Pract 1991;17-18.
4. Ainsworth DM, Yeager AE, Eicker SW, et al. Athletic performance of horses previously infected with Rhodococcus equi pneumonia as foals, in Proceedings. 43rd Annu Conv Am Assoc Equine Pract 1997;81-82.
5. Lakritz J, Wilson WD, Mihalyi JE. Comparison of microbiologic and high-performance liquid chromatography assays to determine plasma concentrations, pharmacokinetics, and bioavailability of erythromycin base in plasma of foals after intravenous or intragastric administration. Am J Vet Res 1999;60:414-419.
6. Traub-Dargatz JL, Wilson WD, Conboy HS, et al. Hyperthermia in foals treated with erythromycin alone or in combination wilh rifampin for respiratory disease during hot environmental conditions, in Proceedings. 42nd Annu Conv Am Assoc Equine Pract 1996;243-244.
7. Lakritz J, Wilson WD, Marsh AE, et al. Pharmacokinetics of erythromycin estolate and erythromycin phosphate after intragastric administration to healthy foals. Am J Vet Res 2000;61: 914-919.
8. Fraser DG. Selection of an oral erythromycin product. Am J Hosp Pharmacol 1980;37:1199-1205.
9. Prescott JF, Sweeney CR. Treatment of Corynebacterium equi pneumonia of foals: a review. J Am Vet Med Assoc 1985;187:725-728.
10. Prescott JF, Hoover DJ, Dohoo IR. Pharmacokinetics of erythromycin in foals and adult horses. J Vet Pharmacol Ther 1983;6:67-73.
11. Ewing PJ, Burrows G, MacAllister C, et al. Comparison of oral erythromycin formulations in the horse using pharmacokinetic profiles. J Vet Pharmacol Ther 1994;17:17-23.
12. Heinzel G, Woloszczak R, Thomann P. Section 2. Topfit 2.0. Pharmacokinetic and pharmacodynamic data analysis system for the PC user's guide. Non-compartmental analysis methods manual. New York: Gustav Fischer, 1993;2-34.
13. Gibaldi M. Compartmental and non-compartmental pharmacokinetics. Biopharmaceutics and clinical pharmacokinetics. 4th ed. Philadelphia: Lea & Febiger, 1991;17-18.
14. SPSS Inc. Comparing two or more groups. SigmaStat for Windows, version 2.03 user's manual Chicago: SPSS Inc, 1997:1-120.